Fundamental dimension Equity attribute | AVVIYLeader $19.17▼-0.52% Cap $28.67BP/E 39.1x QuantScore78/100 | AIGPeer $81.26▼-2.13% Cap $43.08BP/E 14.7x QuantScore56/100 | ALIZYPeer $47.82▼-1.50% Cap $181.8BP/E 14.0x QuantScore77/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
93/100 |
87/100 |
78/100 |
Valuation Multiples, PEG & DCF upside | 86/100 | 79/100 | 98/100 |
Health Piotroski, Altman Z, leverage & liquidity | 32/100 | 50/100 | 45/100 |
Growth Revenue / earnings growth & margins | 79/100 | 34/100 | 62/100 |
Sentiment Analyst ratings, targets & revisions | 100/100 | 31/100 | 100/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 39.1x | 14.7x | 14.0x |
Forward P/E (next FY) | 11.9x | 10.0x | 13.8x |
EV / EBITDA (TTM) | 3.1x | 6.7x | 9.6x |
Price / Sales | 0.3x | 1.6x | 1.0x |
Price / Free Cash Flow | 4.6x | 11.2x | 8.4x |
PEG ratio | -1.80 | 6.10 | 0.82 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 7 / 9 | 5 / 9 |
Altman Z-Score | -0.06 (Distress) | 1.05 (Distress) | 0.05 (Distress) |
Total debt / equity | 0.68 | 0.22 | 0.54 |
Quick ratio | 0.3x | 1.4x | 0.0x |
Interest coverage | 3.1x | 9.2x | 30.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +152.6% | -1.8% | +0.7% |
Net income growth YoY | +51.2% | +320.5% | +8.5% |
Gross margin (TTM) | 66.6% | 38.1% | 85.1% |
Operating margin (FY) | 5.0% | 14.5% | 11.2% |
FCF margin (FY) | -4.8% | 12.4% | 22.0% |
5. Trailing price performancePrice change over period |
1M return | +3.2% | +8.6% | +0.3% |
3M return | +3.9% | +2.8% | -1.3% |
6M return | +12.7% | +8.1% | +4.8% |
Year to date | +2.2% | -5.0% | +4.0% |
1Y return | +6.0% | +2.9% | +16.8% |
3Y return | +95.2% | +35.7% | +107.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $48.40 +152.5% upside | $332.07 +308.6% upside | $84.93 +77.6% upside |
Wall Street consensus target | — — | $86.25 +6.1% · range $80.00–$98.00 | — — |
Consensus stance | 100% Buy0% Hold0% Sell | 37% Buy61% Hold2% Sell | 100% Buy0% Hold0% Sell |